Hosted by: Abbott
No invitations necessary; open to all conference registrants
Tuesday, 6 December
CTICC room location: 1.4
1. Clinicians, health programme workers, researchers
2. Medical technicians, scientists
3. Advocates, public health professionals
4. Policy-makers involved in the testing and treatment of HIV patients
The demands on the laboratory has never been greater: increasing efficiency with current or less resources does require new approaches to cope with this challenge.
Learn more about
- Key success factors for scaling up HIV-1 viral load monitoring by dried-blood-spot testing and the performance of the recently launched HIV-1 one-spot-DBS assay.
- A rapid, low cost option for identifying cases of malaria infection in blood samples undergoing routine blood-counting using the CELL-DYN Ruby Hematology analyzer.
- AlinIQ AMS, a scalable solution connecting the LIS to any automated laboratory analyzer, enabling laboratories to achieve measurably better performance through continuous process improvements.
SESSION LEARNING OBJECTIVES:
1. Learn more about the key success factors for scaling up HIV-1 viral load monitoring by dried-blood-spot testing and the performance of the recently launched HIV-1 one-spot-DBS assay.
2. Discover a rapid, low cost option for identifying Malaria in blood samples.
3. Learn how to achieve measurably better performance through AlinIQ.
- Michael Palm – Abbott Molecular, Introduction
- Charles Kiyaga – Ministry of Health – Uganda, Successful scale up of Centralized HIV Dried Blood Spot testing in Uganda
- Sergio Carmona – National Health Laboratory Service, South Africa, Abbott RealTime HIV-1 DBS – The first experience at NHLS
- Hans Hoffmann – Abbott Hematology, Malaria detection by the CELL-DYN Ruby hematology analyzer
- Adam Randolph – Abbott Diagnostics, AlinIQ Discover greater operational productivity with existing resources